Literature DB >> 7009289

Haloperidol and insulin release.

F Lechin, B van der Dijs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009289     DOI: 10.1007/bf00253822

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Hallucinogen binding to dopamine/neuroleptic receptors.

Authors:  P M Whitaker; P Seeman
Journal:  J Pharm Pharmacol       Date:  1977-08       Impact factor: 3.765

2.  The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.

Authors:  F Lechin; E Coll-García; B van der Dijs; A Bentolila; F Peña; C Rivas
Journal:  Experientia       Date:  1979-07-15

3.  Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.

Authors:  I Lundquist; R Ekholm; L E Ericson
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

4.  The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.

Authors:  J M Monti
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

5.  Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

6.  Reinterpretation of the effect of haloperidol and ethanol on insulin secretion.

Authors:  E Samols; J I Stagner
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

  6 in total
  1 in total

1.  Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms.

Authors:  Fuad Lechin; Bertha van der Dijs; Betty Pardey-Maldonado; Jairo E Rivera; Marcel E Lechin; Scarlet Baez
Journal:  Diabetes Metab Syndr Obes       Date:  2009-12-02       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.